Month: January 2019

Temperature-stable experimental tuberculosis vaccine enters clinical testing

Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis (TB) vaccine candidate. Continue reading on the National Institutes of Health website. DF/Net has been working with the Infectious Disease Research Institute (IDRI) in Seattle since 2004: they were our second client! We’ve worked on phase …

Temperature-stable experimental tuberculosis vaccine enters clinical testing Read More »